Macrophage metabolism in atherosclerosis

被引:125
|
作者
Bories, Gael F. P.
Leitinger, Norbert [1 ,2 ]
机构
[1] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave,Pinn Hall, Charlottesville, VA 22908 USA
[2] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, 1340 Jefferson Pk Ave,Pinn Hall, Charlottesville, VA 22908 USA
关键词
atherosclerosis; macrophage; metabolism; ACTIVATED PROTEIN-KINASE; HYPOXIA-INDUCIBLE FACTOR; FOAM CELL-FORMATION; FATTY-ACID OXIDATION; APOPTOTIC CELLS; NITRIC-OXIDE; ALTERNATIVE ACTIVATION; CARDIOVASCULAR-DISEASE; GENE-EXPRESSION; FRUCTOSE 2,6-BISPHOSPHATE;
D O I
10.1002/1873-3468.12786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A key aspect of atherosclerosis is the maladaptive inflammatory response to lipoprotein accumulation in the artery. The failure to decrease lipid accumulation, to clear apoptotic cells, and to resolve inflammation ultimately leads to macrophage accumulation within the vascular wall [Thorp EB (2010) Apoptosis 15, 1124-1136; Moore K etal. (2013) Nat Rev Immunol 13, 709-721; Moore KJ and Tabas I (2011) Cell 145, 341-355; Ley K etal. (2011) Arterioscler Thromb Vasc Biol 31, 1506-1516]. Several subsets of macrophages are found inside atherosclerotic plaques [Chinetti-Gbaguidi G etal. (2015) Nat Rev Cardiol 12, 10-17; Leitinger N and Schulman IG (2013) Arterioscler Thromb Vasc Biol 33, 1120-1126; Mantovani A etal. (2009) Arterioscler Thromb Vasc Biol 29, 1419-1423]: Proinflammatory M1-like macrophages potentially participate in atherosclerosis initiation and progression; M2-like macrophages are thought to be protective due to their anti-inflammatory and profibrotic properties, presumably stabilizing the plaque [Chistiakov DA etal. (2015) Int J Cardiol 184, 436-445; Gordon S (2003) Nat Rev Immunol 3, 23-35]; Mox macrophages develop in response to oxidized phospholipids and present a glutathione- and potentially redox-regulating phenotype [Kadl A etal. (2010) Circ Res 107, 737-746]; Mhem macrophages are found in areas of plaque hemorrhage [Boyle JJ etal. (2009) Am J Pathol 174, 1097-1108; Boyle JJ etal. (2012) Circ Res 110, 20-33] where they are involved in heme clearance. Recent evidence suggests that the relative abundance of these macrophage subsets is a better indicator of plaque progression and stability than the total number of lesion macrophages [Chinetti-Gbaguidi G etal. (2015) Nat Rev Cardiol 12, 10-17]. Over the last few years, findings in the area of immunometabolism established a link between the metabolic state of the different macrophage phenotypes and their functions [O'Neill LAJ and Pearce EJ (2016) J Exp Med 213, 15-23]. However, the effect of metabolic changes in macrophages on atherosclerotic plaque progression and stability is not well understood and an area of intensive study. In this review, we will summarize and critically discuss recent developments in the field of macrophage metabolism in the context of atherosclerosis to guide future investigation in this area.
引用
收藏
页码:3042 / 3060
页数:19
相关论文
共 50 条
  • [1] Emerging nanomaterials targeting macrophage adapted to abnormal metabolism in cancer and atherosclerosis therapy (Review)
    Xu, Miaomiao
    Cui, Ying
    Wei, Siyuan
    Cong, Xuelong
    Chen, Yiying
    Tian, Shujie
    Yao, Anqi
    Chen, Weiwei
    Weng, Lixing
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2024, 53 (02)
  • [2] Macrophage Metabolism As Therapeutic Target for Cancer, Atherosclerosis, and Obesity
    Geeraerts, Xenia
    Bolli, Evangelia
    Fendt, Sarah-Maria
    Van Ginderachter, Jo A.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [3] Macrophage Polarization in Atherosclerosis
    Eshghjoo, Sahar
    Kim, Da Mi
    Jayaraman, Arul
    Sun, Yuxiang
    Alaniz, Robert C.
    GENES, 2022, 13 (05)
  • [4] Intracellular and Intercellular Aspects of Macrophage Immunometabolism in Atherosclerosis
    Tabas, Ira
    Bornfeldt, Karin E.
    CIRCULATION RESEARCH, 2020, 126 (09) : 1209 - 1227
  • [5] Targeting Macrophage Phenotypes and Metabolism as Novel Therapeutic Approaches in Atherosclerosis and Related Cardiovascular Diseases
    Wang, Juan
    Wu, Qiang
    Wang, Xinyu
    Liu, Hongbin
    Chen, Mulei
    Xu, Li
    Zhang, Ze
    Li, Kuibao
    Li, Weiming
    Zhong, Jiuchang
    CURRENT ATHEROSCLEROSIS REPORTS, 2024, 26 (10) : 573 - 588
  • [6] Metformin, Macrophage Dysfunction and Atherosclerosis
    Feng, Xiaojun
    Chen, Wenxu
    Ni, Xiayun
    Little, Peter J.
    Xu, Suowen
    Tang, Liqin
    Weng, Jianping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Macrophage energy metabolism in cardiometabolic disease
    Wong, Angela
    Sun, Qiuyu
    Latif, Ismail I.
    Karwi, Qutuba G.
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (03) : 1763 - 1783
  • [8] Macrophage fatty acid oxidation in atherosclerosis
    Xiao, Sujun
    Qi, Mingxu
    Zhou, Qinyi
    Gong, Huiqin
    Wei, Duhui
    Wang, Guangneng
    Feng, Qilun
    Wang, Zhou
    Liu, Zhe
    Zhou, Yiren
    Ma, Xiaofeng
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 170
  • [9] Macrophage Diversity and Polarization in Atherosclerosis A Question of Balance
    Mantovani, Alberto
    Garlanda, Cecilia
    Locati, Massimo
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (10) : 1419 - 1423
  • [10] Mitochondria orchestrate macrophage effector functions in atherosclerosis
    Dumont, Adelie
    Lee, Man K. S.
    Barouillet, Thibault
    Murphy, Andrew
    Yvan-Charvet, Laurent
    MOLECULAR ASPECTS OF MEDICINE, 2021, 77